Floragenex Launches Biota Sciences to Provide Focused Expertise to Life Science Researchers

Jan. 9, 2010 - PRLog -- Life science researchers have a new partner in custom genomic research – Biota Sciences.

Launched by Floragenex to leverage its proprietary next-gen sequencing technology for researchers in vertebrate, invertebrate and other species, Biota Sciences provides services focused on meeting its clients’ research goals.

“Through Floragenex and Biota Sciences, we can create solutions for plant and animal researchers with our suite of sequencing technologies,” says Nathan Lillegard, Floragenex CEO. “We provide more sequence information per dollar, more detailed bioinformatics analysis custom tailored to our clients’ research design. Our services enable our customers to focus on their biology and analysis, rather than navigating the challenges of matching their goals with technology.”

Biota Sciences Services:
   •   SNP discovery and assay development: With or without a reference genome, services engagements are focused on delivering research ready date to be converted for your SNP genotyping system of choice.
   •   Linkage Mapping/Positional Cloning: Identifying polymorphic sequences associated with your trait or gene of interest as a critical tool for marker assisted selection and gene discovery efforts.
   •   Custom Genomic Research: Genome-wide association studies, targeted resequencing, physical map development, and whole genome sequencing projects are planned, executed, and delivered to meet your objectives and match your budget.

Supported by the resources and experience of the Floragenex lab and bioinformatics team, Biota Sciences services are lead by Dr. Jason Boone. Dr. Boone brings a genuine passion for enabling advances in genomics for all species. Biota Sciences engagements include meiotic mapping in model fish species, phylogenetic analysis of emerging research organisms, and evolutionary questions in endangered species.

# # #

About Floragenex:
Floragenex was founded in 2006 as a spinout of the University of Oregon, focused on commercializing the Restriction site Associated DNA (RAD) technology developed by co-founder and University of Oregon professor Dr. Eric Johnson. The company's vision is to enable discovery by bringing advanced genomic technology to all species.